Evaluation of factors associated with acceptance of adherence and toxicity levels in the treatment of tuberculosis infection and effectiveness of the treatment

Lazaru P; Suresh Kumar J. N; Pavani Reddy G; Bindu Madhavi M; Amina Sk; Ravi Kumar  CH; Vamsi S

doi:10.47957/ijpda.v12i1.583

Authors

P. Lazaru Department of Pharmacy Practice, Narasaraopeta Institute of Pharmaceutical Sciences, Kotappakonda road, Yallamanda, Narasaraopeta, Palnadu, Andhra Pradesh, India
J. N. Suresh Kumar Department of Pharmacy Practice, Narasaraopeta Institute of Pharmaceutical Sciences, Kotappakonda road, Yallamanda, Narasaraopeta, Palnadu, Andhra Pradesh, India
G. Pavani Reddy Department of Pharmacy Practice, Narasaraopeta Institute of Pharmaceutical Sciences, Kotappakonda road, Yallamanda, Narasaraopeta, Palnadu, Andhra Pradesh, India
M. Bindu Madhavi Department of Pharmaceutical Analysis, Narasaraopeta Institute of Pharmaceutical Sciences, Kotappakonda road, Yallamanda, Narasaraopeta, Palnadu, Andhra Pradesh, India
Sk. Amina Department of Pharmacy Practice, Narasaraopeta Institute of Pharmaceutical Sciences, Kotappakonda road, Yallamanda, Narasaraopeta, Palnadu, Andhra Pradesh, India
CH. Ravi Kumar Department of Pharmacy Practice, Narasaraopeta Institute of Pharmaceutical Sciences, Kotappakonda road, Yallamanda, Narasaraopeta, Palnadu, Andhra Pradesh, India
S. Vamsi Department of Pharmacy Practice, Narasaraopeta Institute of Pharmaceutical Sciences, Kotappakonda road, Yallamanda, Narasaraopeta, Palnadu, Andhra Pradesh, India

DOI:

https://doi.org/10.47957/ijpda.v12i1.583

Keywords:

Tuberculosis Introduction, Adherence, Toxicity, Treatment

Abstract

Tuberculosis treatment remains a challenge due to the need to consider, when approaching it, the context of individual and collective health. In addition, social and economic issues have been shown to be variables that need to be considered when it comes to treatment effectiveness. In a small proportion of cases, the bacillus is transmitted to humans from infected cows through drinking non-sterilized milk. This mode of transmission plays only a minor role in the natural history of the disease in humans. This study explores factors influencing acceptance of adherence and toxicity levels in tuberculosis treatment, aiming to assess their impact on treatment effectiveness. Through comprehensive evaluation, aim to identify key variables contributing to patient compliance and potential barriers to successful outcomes, shedding light on optimizing tuberculosis treatment strategies.

Downloads

Download data is not yet available.

References

"Tuberculosis (TB)". who.int. Archived from the original on 30 July 2020. Retrieved 8 May 2020

The Chambers Dictionary. New Delhi: Allied Chambers India Ltd. 1998. p. 352. ISBN 978-81-86062-25-8. Archived from the original on 6 September 2015.

Adkinson NF, Bennett JE, Douglas RG, Mandell GL (2010). Mandell, Douglas, and Bennett's principles and practice of infectious diseases (7th ed.). Philadelphia, PA: Churchill Livingstone/Elsevier. p. Chapter 250

Pearce-Duvet JM (August 2006). "The origin of human pathogens: evaluating the role of agriculture and domestic animals in the evolution of human disease". Biological Reviews of the Cambridge Philosophical Society. 81 (3): 369–82

The word "tuberculosis" first appeared in Schönlein's clinical notes in 1829. See: Jay SJ, K?rb?y?k U, Woods JR, Steele GA, Hoyt GR, Schwengber RB, Gupta P (November 2018). "Modern theory of tuberculosis: culturomic analysis of its historical origin in Europe and North America". The International Journal of Tuberculosis and Lung Disease. 22 (11): 1249–1257.

Villemin JA (1865). "Cause et nature de la tuberculose" [Cause and nature of tuberculosis]. Bulletin de l'Académie Impériale de Médecine (in French). 31: 211–216

Burdon-Sanderson, John Scott. (1870) "Introductory Report on the Intimate Pathology of Contagion." Appendix to: Twelfth Report to the Lords of Her Majesty's Most Honourable Privy Council of the Medical Officer of the Privy Council [for the year 1869], Parliamentary Papers (1870), vol. 38, 229–256

"History: World TB Day". Centers for Disease Control and Prevention (CDC). 12 December 2016. Archived from the original on 7 December 2018. Retrieved 23 March 2019

Gordon SV, Parish T (April 2018). "Microbe Profile: Mycobacterium tuberculosis: Humanity's deadly microbial foe". Microbiology. 164 (4): 437–439

Ryan KJ, Ray CG (2004). "Mycobacteria". Sherris Medical Microbiology : an Introduction to Infectious Diseases (4th ed.). New York: McGraw-Hill. p. 439

Fu LM, Fu-Liu CS (1 January 2002). "Is Mycobacterium tuberculosis a closer relative to Gram-positive or Gram-negative bacterial pathogens?". Tuberculosis. 82 (2–3): 85–90

Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornsby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG (June 1998). "Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence". Nature. 393 (6685): 537–44

Camus JC, Pryor MJ, Médigue C, Cole ST (October 2002). "Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv". Microbiology. 148 (Pt 10): 2967–73

Saleeb PG, Drake SK, Murray PR, Zelazny AM (May 2011). "Identification of mycobacteria in solid-culture media by matrix-assisted laser desorption ionization-time of flight mass spectrometry". Journal of Clinical Microbiology. 49 (5): 1790–94

Muñoz L, Stagg HR, Abubakar I. Diagnosis and management of latent tuberculosis infection.Cold Spring Harbor perspectives in medicine. 2015 Nov;5(11).

DRuSZCZY?SKA M, Kowalewicz-Kulbat M, Fol M, W?ODARCZYK M, RuDnICKA W. LatentM. tuberculosis infection--pathogenesis, diagnosis, treatment and prevention strategies. Pol JMicrobiol. 2012 Jan 1;61(1):3-10.

Kaona FA, Tuba M, Siziya S, Sikaona L. An assessment of factors contributing to treatmentadherence and knowledge of TB transmission among patients on TB treatment. BMC Publichealth. 2004 Dec;4(1):1-8.

Carmona L, Gómez?Reino JJ, Rodríguez?Valverde V, Montero D, Pascual?Gómez E, Mola EM,Carreño L, Figueroa M, BIOBADASER Group. Effectiveness of recommendations to preventreactivation of latent tuberculosis infection in patients treated with tumor necrosis factorantagonists. Arthritis & Rheumatism. 2005 Jun;52(6):1766-72.

Page KR, Sifakis F, De Oca RM, Cronin WA, Doherty MC, Federline L, Bur S, Walsh T, KarneyW, Milman J, Baruch N. Improved adherence and less toxicity with rifampin vs isoniazid fortreatment of latent tuberculosis: a retrospective study. Archives of Internal Medicine. 2006Sep 25;166(17):1863-70.

Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence totuberculosis treatment: a systematic review of qualitative research. PLoS medicine. 2007Jul;4(7):e238.

Frydenberg AR, Graham SM. Toxicity of first?line drugs for treatment of tuberculosis inchildren. Tropical Medicine & International Health. 2009 Nov;14(11):1329-37.

Sánchez-García EM, Gamallo R, Blanco-Moure A, Viejo MA, Amador L, Anibarro L. Toxicityand adherence to treatment for latent tuberculosis infection in patients with hematologicmalignancies. Infection. 2013 Oct;41:903-7.

Stagg HR, Zenner D, Harris RJ, Muñoz L, Lipman MC, Abubakar I. Treatment of latenttuberculosis infection: a network meta-analysis. Annals of internal medicine. 2014 Sep16;161(6):419-28.

Gashu KD, Gelaye KA, Tilahun B. Adherence to TB treatment remains low duringcontinuation phase among adult patients in Northwest Ethiopia. BMC Infectious Diseases.2021 Dec;21(1):1-0.